Jazz Pharmaceuticals
JAZZ
$112.01
Share price
-1.03%
Change (1 day)
-16.83%
Change (1 year)
Categories
Earnings for Jazz Pharmaceuticals (JAZZ)
Earnings in 2023 (TTM): $0.29 B
According to Jazz Pharmaceuticals's latest financial reports the company's current earnings (TTM) are $0.24 B. In 2022 the company made an earning of -$0.38 B a decrease over its 2021 earnings that were of -$0.12 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Jazz Pharmaceuticals from 2005 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | $0.29 B | -179.92% |
| 2022 | -$0.38 B | 230.37% |
| 2021 | -$0.12 B | -141.02% |
| 2020 | $0.27 B | -39.45% |
| 2019 | $0.45 B | -14.2% |
| 2018 | $0.52 B | 20.03% |
| 2017 | $0.44 B | -17.15% |
| 2016 | $0.53 B | 22.14% |
| 2015 | $0.43 B | 187.64% |
| 2014 | $0.15 B | -50.79% |
| 2013 | $0.30 B | 73.63% |
| 2012 | $0.17 B | 41.69% |
| 2011 | $0.12 B | 116.61% |
| 2010 | $57.78 M | 262.77% |
| 2009 | $15.93 M | -111.33% |
| 2008 | -$0.15 B | 1.31% |
| 2007 | -$0.14 B | 77.8% |
| 2006 | -$78.06 M | 36.59% |
| 2005 | -$57.15 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $9.82 B | 3,973.77% | 🇨🇭 Switzerland |
 AmerisourceBergen
ABC | $2.09 B | 769.21% | 🇺🇸 USA |
 Endo International
ENDPQ | -$2.4 B | -1,091.57% | 🇮🇪 Ireland |
 Teva Pharmaceutical Industries TEVA | $0.40 B | 67.89% | 🇮🇱 Israel |